Market Forecast By Prescription Type (Prescription Drugs, Over-the-Counter Drugs), By Drug Type (Branded Drugs, Generic Drugs, Branded Generic Drugs), By Drug Class (Small Molecules, Biologics, Biosimilars), By Indication (Cardiovascular Diseases, Immunology, Respiratory Diseases, Neurological Diseases, Infectious Diseases, Skin Diseases), By Mode of Administration (Topical, Oral, Injectable, Intra-nasal, Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Drug Stores, Online Pharmacies) And Competitive Landscape
| Product Code: ETC8264618 | Publication Date: Sep 2024 | Updated Date: Dec 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Dhaval Chaurasia | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
According to 6Wresearch internal database and industry insights, the Mauritius Pharmaceutical Market is projected to grow at a compound annual growth rate (CAGR) of 8.3% during the forecast period from 2026 to 2032.
Below mentioned are the evaluation of year-wise growth rate along with key drivers:
| Year | Est. Annual Growth (%) | Growth Drivers |
| 2021 | 6.5% | Increasing expenditure on healthcare and growing demand for prescription drugs. |
| 2022 | 6.8% | Expansion of sales pharmacies, and high risk of chronic disease. |
| 2023 | 700.00% | Growth in biologics and biosimilars has improved healthcare infrastructure, and government health policies. |
| 2024 | 7.3% | Increasing risk of lifestyle diseases, higher usage of over-the-counter drugs, and new private hospitals. |
| 2025 | 7.5% | New technologies in drug delivery and collaborations with international pharmaceutical. |
The Mauritius Pharmaceutical Market report thoroughly covers the market by prescription type, drug type, drug class, indication, mode of administration, and distribution channel. It provides an unbiased and detailed analysis of ongoing market trends, opportunities, challenges, and market drivers, helping stakeholders align their strategies with current and future market dynamics.
| Report Name | Mauritius Pharmaceutical Market |
| Forecast Period | 2026–2032 |
| CAGR | 8.30% |
| Growing Sector | Healthcare & Pharmaceuticals |
Mauritius Pharmaceutical Market is expected to witness major growth as it is driven by increasing risks of chronic diseases, major healthcare awareness, and new and expanding infrastructure of healthcare. The increasing number of partnerships between local and international pharmaceutical companies improves the drug portfolio available in Mauritius. Overall, the market has a major growth potential due to the increasing demand for prescription and over-the-counter medications across all age groups. Mauritius Pharmaceutical Market Growth is also supported by major government programs for affordable medicine access, rising usage of generic and biosimilar drugs, and expansion of retail and hospital pharmacies.
Below mentioned are some prominent drivers and their impact on the Malaysia Pharmaceutical Market dynamics:
| Drivers | Primary Segment Affected | Why It Matters (Evidence) |
| Rising Chronic Diseases | Prescription Drugs, OTC Drugs | Increasing risk of cardiovascular, diabetes, and respiratory diseases creates demand of pharmaceutical products. |
| Government Healthcare Programs | All Segments | Programs like National Health Insurance Scheme and subsidies on important medicines improve access and price range. |
| Expanding Retail & Hospital Pharmacies | All Segments | Growth of new hospital and retail pharmacy improves availability of drug and its usage in urban and rural areas. |
| Rising Awareness & Health Literacy | All Segments | Major health awareness increase demand in healthcare and also consumption of prescription and OTC medicines. |
| International Collaborations | Branded Drugs, Biologics | Partnerships with global pharma companies that introduce new drugs in the market and improve the quality of medicines. |
Mauritius Pharmaceutical Market Size is projected to grow at a CAGR of 8.3% from 2026 to 2032. Some important drivers include the increasing risk of chronic diseases, government healthcare programs, expansion of better healthcare infrastructure, and collaborations with international pharmaceutical. The market is also supported by rising usage of generic drugs and biosimilars, which provide cost-effective options in place of branded medicines. Overall, the market has a major growth potential due to the increasing demand for prescription and over-the-counter medications across all age groups. Increasing awareness and rising healthcare spending also improve the growth potential of Mauritius Pharmaceutical Industry.
Below mentioned are some major restraints and their influence on the Malaysia Pharmaceutical Market dynamics:
| Restraints | Primary Segment Affected | What This Means (Evidence) |
| High Cost of Branded Drugs | Branded Drugs | High prices of branded drugs may reduce their access for those patients who are low-income. |
| Regulatory Compliance | All Segments | Complex processes of drug approval and strict regulatory laws can delay launches of new products. |
| Limited Local Manufacturing | Branded and Biologics | Heavy dependence on imports increases prices and affects reliability on supply. |
| Economic Constraints | All Segments | Due to limited income of some population segments, they may reduce expenditure on medicines. |
| Counterfeit Drugs | OTC and Generic Drugs | Presence of fraud medicines can reduce trust in available products. |
Mauritius Pharmaceutical Market faces many challenges such as high prices of branded drugs, regulatory difficulties, limited capacity of local manufacturing, and economic ups-down on consumers. The heavy dependence on imported medicines can also change their pricing and availability. Counterfeit medicines and limited local production of medicines also create further challenges in the market. Slow development of advanced therapies and their limited awareness in rural areas may restrict market’s demand. Some distribution channels and logistical inefficiencies also increase time of delivery of essential medicines across the country.
Major trends that are changing the Mauritius Pharmaceutical Market dynamics are:
Some new investment opportunities in the Mauritius Pharmaceutical Industry are:
Below is the list of prominent companies leading in the Mauritius Pharmaceutical Market:
| Company Name | Sanofi S.A. |
| Established Year | Paris, France |
| Headquarters | 1973 |
| Official Website | Click Here |
Sanofi is a global pharmaceutical company operating in Mauritius, offering a wide range of branded and generic drugs across multiple therapeutic areas, including cardiovascular and immunology.
| Company Name | Novartis AG |
| Established Year | Basel, Switzerland |
| Headquarters | 1996 |
| Official Website | Click Here |
Novartis provides innovative medicines and biosimilars in Mauritius, focusing on oncology, neurological, and respiratory treatments.
| Company Name | GlaxoSmithKline (GSK) |
| Established Year | Brentford, UK |
| Headquarters | 2000 |
| Official Website | Click Here |
GSK Mauritius offers vaccines, prescription, and OTC drugs, with a focus on respiratory, infectious diseases, and skin disorders.
| Company Name | Cipla Ltd. |
| Established Year | Mumbai, India |
| Headquarters | 1935 |
| Official Website | Click Here |
Cipla specializes in generic medicines, supplying affordable options for cardiovascular, respiratory, and chronic disease management in Mauritius.
| Company Name | United Laboratories Ltd. |
| Established Year | Port Louis, Mauritius |
| Headquarters | 1982 |
| Official Website | Click Here |
United Laboratories is a leading local pharmaceutical manufacturer producing a variety of branded and generic drugs, catering to the domestic market.
According to Mauritius’s government data, they have implemented many new policies to strengthen the pharmaceutical sector of Mauritius, such as: National Health Insurance Scheme, Medicines Regulatory Authority for approval of drug, tax incentives for local manufacturers to increase local production, and subsidies for production of essential drugs. Many new programs are also started to promote local consumer’s access to affordable medicines and increase local production of generic and biosimilar drugs. The government also push partnerships between public-private firms, to attract foreign investment and better pharmaceutical technologies.
Mauritius Pharmaceutical Market is expected to continue its steady growth in the upcoming years as it is driven by high risks of chronic diseases, government healthcare programs, and expansion of new hospital and retail pharmacies. The increasing usage of generics and biosimilars and partnerships with international pharmaceutical companies, will also likely to increase demand in the market. Growth in digital pharmacies and integration of telehealth will improve its accessibility and positions Mauritius as an important pharmaceutical hub in the region. The market has a major growth potential due to the increasing demand for prescription and over-the-counter medications in all age groups.
The report offers a comprehensive study of the following market segments and their leading categories:
According to Lakshita, Senior Research Analyst, 6Wresearch, Prescription Drugs dominate the Mauritius market due to increasing risk of chronic and lifestyle-related diseases such as including cardiovascular, diabetes, and immunological disorders.
Branded Generic Drugs are dominating, as they provide a balance between affordability and quality. They are widely famous in Mauritius for treating chronic conditions while keeping prices less, driving strong use in hospitals and retail pharmacies.
Small Molecules dominate the Mauritius Pharmaceutical Market Share, due to their wide usage in chronic and acute conditions, ease of manufacturing, and price range compared to biologics. Biologics and biosimilars demand are increasing particularly in immunology.
Cardiovascular Diseases dominate this segment due to high numbers in aging population and rising lifestyle diseases. Other indications such as immunology and respiratory diseases are also growing with increased awareness and treatment options.
Oral drugs dominate due to their ease of use, patient compliance, and cost efficiency. Injectable and topical formulations are used in therapies, while intra-nasal and other methods remain limited but innovative.
Retail Pharmacies dominate as the main source for medicines due to their easy accessibility, convenience, and strong demand in urban and semi-urban areas. Hospital pharmacies are also important for prescription drugs.
The report offers a comprehensive study of the following Mauritius Pharmaceutical Market segments:
| 1 Executive Summary |
| 2 Introduction |
| 2.1 Key Highlights of the Report |
| 2.2 Report Description |
| 2.3 Market Scope & Segmentation |
| 2.4 Research Methodology |
| 2.5 Assumptions |
| 3 Mauritius Pharmaceutical Market Overview |
| 3.1 Mauritius Country Macro Economic Indicators |
| 3.2 Mauritius Pharmaceutical Market Revenues & Volume, 2022 & 2032F |
| 3.3 Mauritius Pharmaceutical Market - Industry Life Cycle |
| 3.4 Mauritius Pharmaceutical Market - Porter's Five Forces |
| 3.5 Mauritius Pharmaceutical Market Revenues & Volume Share, By Prescription Type, 2022 & 2032F |
| 3.6 Mauritius Pharmaceutical Market Revenues & Volume Share, By Drug Type, 2022 & 2032F |
| 3.7 Mauritius Pharmaceutical Market Revenues & Volume Share, By Drug Class, 2022 & 2032F |
| 3.8 Mauritius Pharmaceutical Market Revenues & Volume Share, By Indication, 2022 & 2032F |
| 3.9 Mauritius Pharmaceutical Market Revenues & Volume Share, By Mode of Administration, 2022 & 2032F |
| 3.10 Mauritius Pharmaceutical Market Revenues & Volume Share, By Distribution Channel, 2022 & 2032F |
| 4 Mauritius Pharmaceutical Market Dynamics |
| 4.1 Impact Analysis |
| 4.2 Market Drivers |
| 4.3 Market Restraints |
| 5 Mauritius Pharmaceutical Market Trends |
| 6 Mauritius Pharmaceutical Market, By Types |
| 6.1 Mauritius Pharmaceutical Market, By Prescription Type |
| 6.1.1 Overview and Analysis |
| 6.1.2 Mauritius Pharmaceutical Market Revenues & Volume, By Prescription Type, 2022 & 2032F |
| 6.1.3 Mauritius Pharmaceutical Market Revenues & Volume, By Prescription Drugs, 2022 & 2032F |
| 6.1.4 Mauritius Pharmaceutical Market Revenues & Volume, By Over-the-Counter Drugs, 2022 & 2032F |
| 6.2 Mauritius Pharmaceutical Market, By Drug Type |
| 6.2.1 Overview and Analysis |
| 6.2.2 Mauritius Pharmaceutical Market Revenues & Volume, By Branded Drugs, 2022 & 2032F |
| 6.2.3 Mauritius Pharmaceutical Market Revenues & Volume, By Generic Drugs, 2022 & 2032F |
| 6.2.4 Mauritius Pharmaceutical Market Revenues & Volume, By Branded Generic Drugs, 2022 & 2032F |
| 6.3 Mauritius Pharmaceutical Market, By Drug Class |
| 6.3.1 Overview and Analysis |
| 6.3.2 Mauritius Pharmaceutical Market Revenues & Volume, By Small Molecules, 2022 & 2032F |
| 6.3.3 Mauritius Pharmaceutical Market Revenues & Volume, By Biologics, 2022 & 2032F |
| 6.3.4 Mauritius Pharmaceutical Market Revenues & Volume, By Biosimilars, 2022 & 2032F |
| 6.4 Mauritius Pharmaceutical Market, By Indication |
| 6.4.1 Overview and Analysis |
| 6.4.2 Mauritius Pharmaceutical Market Revenues & Volume, By Cardiovascular Diseases, 2022 & 2032F |
| 6.4.3 Mauritius Pharmaceutical Market Revenues & Volume, By Immunology, 2022 & 2032F |
| 6.4.4 Mauritius Pharmaceutical Market Revenues & Volume, By Respiratory Diseases, 2022 & 2032F |
| 6.4.5 Mauritius Pharmaceutical Market Revenues & Volume, By Neurological Diseases, 2022 & 2032F |
| 6.4.6 Mauritius Pharmaceutical Market Revenues & Volume, By Infectious Diseases, 2022 & 2032F |
| 6.4.7 Mauritius Pharmaceutical Market Revenues & Volume, By Skin Diseases, 2022 & 2032F |
| 6.5 Mauritius Pharmaceutical Market, By Mode of Administration |
| 6.5.1 Overview and Analysis |
| 6.5.2 Mauritius Pharmaceutical Market Revenues & Volume, By Topical, 2022 & 2032F |
| 6.5.3 Mauritius Pharmaceutical Market Revenues & Volume, By Oral, 2022 & 2032F |
| 6.5.4 Mauritius Pharmaceutical Market Revenues & Volume, By Injectable, 2022 & 2032F |
| 6.5.5 Mauritius Pharmaceutical Market Revenues & Volume, By Intra-nasal, 2022 & 2032F |
| 6.5.6 Mauritius Pharmaceutical Market Revenues & Volume, By Others, 2022 & 2032F |
| 6.6 Mauritius Pharmaceutical Market, By Distribution Channel |
| 6.6.1 Overview and Analysis |
| 6.6.2 Mauritius Pharmaceutical Market Revenues & Volume, By Hospital Pharmacies, 2022 & 2032F |
| 6.6.3 Mauritius Pharmaceutical Market Revenues & Volume, By Retail Pharmacies, 2022 & 2032F |
| 6.6.4 Mauritius Pharmaceutical Market Revenues & Volume, By Drug Stores, 2022 & 2032F |
| 6.6.5 Mauritius Pharmaceutical Market Revenues & Volume, By Online Pharmacies, 2022 & 2032F |
| 7 Mauritius Pharmaceutical Market Import-Export Trade Statistics |
| 7.1 Mauritius Pharmaceutical Market Export to Major Countries |
| 7.2 Mauritius Pharmaceutical Market Imports from Major Countries |
| 8 Mauritius Pharmaceutical Market Key Performance Indicators |
| 9 Mauritius Pharmaceutical Market - Opportunity Assessment |
| 9.1 Mauritius Pharmaceutical Market Opportunity Assessment, By Prescription Type, 2022 & 2032F |
| 9.2 Mauritius Pharmaceutical Market Opportunity Assessment, By Drug Type, 2022 & 2032F |
| 9.3 Mauritius Pharmaceutical Market Opportunity Assessment, By Drug Class, 2022 & 2032F |
| 9.4 Mauritius Pharmaceutical Market Opportunity Assessment, By Indication, 2022 & 2032F |
| 9.5 Mauritius Pharmaceutical Market Opportunity Assessment, By Mode of Administration, 2022 & 2032F |
| 9.6 Mauritius Pharmaceutical Market Opportunity Assessment, By Distribution Channel, 2022 & 2032F |
| 10 Mauritius Pharmaceutical Market - Competitive Landscape |
| 10.1 Mauritius Pharmaceutical Market Revenue Share, By Companies, 2025 |
| 10.2 Mauritius Pharmaceutical Market Competitive Benchmarking, By Operating and Technical Parameters |
| 11 Company Profiles |
| 12 Recommendations |
| 13 Disclaimer |